AngioCloud Service— 510(k) K211713

Substantially Equivalent

Angiocloud, LLC

FDA 510(k) clearance K211713 for AngioCloud Service, Substantially Equivalent on 2022-04-28. Applicant: Angiocloud, LLC.

Clearance details

Applicant: Angiocloud, LLC
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2021-06-03
Decision date: 2022-04-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Atlanta, GA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.